MindMaze Therapeutics Holding SA Stock
Stocks
RLF
CH1251125998
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2000 CHF | -8.68% |
|
-9.09% | -89.47% |
| 06-02 | MindMaze Therapeutics Sells North American Rights to Phenylketonuria Program | MT |
| 05-26 | MindMaze Therapeutics Locks in CHF8 Million Equity Financing from Neuro.io Group | MT |
| Market Cap | 30.52M 38.04M 33.24M 28.46M 53.96M 3.62B 54.87M 367M 142M 1.78B 143M 140M 6.12B | P/E 2026 * |
-4.44x | P/E 2027 * | 1.56x |
|---|---|---|---|---|---|
| Enterprise Value | 22.1M 27.54M 24.07M 20.61M 39.07M 2.62B 39.73M 266M 103M 1.29B 103M 101M 4.43B | EV / Sales 2026 * |
3.75x | EV / Sales 2027 * | 0.26x |
| Free-Float |
26.94% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -8.68% | ||
| 1 week | -9.09% | ||
| 1 month | -47.16% | ||
| 3 months | -37.11% | ||
| 6 months | -89.47% | ||
| Current year | -89.47% |
| 1 week | 0.2 |  | 0.26 |
| 1 month | 0.2 | | 0.38 |
| Current year | 0.2 | | 1.87 |
| 1 year | 0.2 | | 2.92 |
| 3 years | 0.2 | | 2.92 |
| 5 years | 0.2 | | 2.92 |
| 10 years | 0.2 | | 2.92 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-18 | Sell | 52,162 | 0.0338% | |||
| 12-18 | Sell | 281,968 | 0.1830% | |||
| 12-18 | Sell | 140,000 | 0.0908% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.68% | -9.09% | - | - | 41.35M | |
| +0.36% | +5.10% | +1.04% | +5.85% | 48.62B | |
| +0.92% | +6.21% | +408.85% | +607.44% | 39.86B | |
| +1.89% | +11.06% | +25.75% | -7.89% | 33.91B | |
| +2.38% | +8.10% | +21.83% | +66.94% | 32.32B | |
| +1.20% | +2.02% | +9.79% | +32.43% | 24.73B | |
| +2.51% | +4.94% | - | - | 16.63B | |
| +2.58% | +7.24% | +71.03% | +132.17% | 15.52B | |
| +0.99% | +1.26% | +13.98% | +18.88% | 13.63B | |
| -1.14% | +7.52% | +14.75% | -30.83% | 13.41B | |
| Average | +0.30% | +4.88% | +70.87% | +103.12% | 23.87B | |
| Weighted average by Cap. | +1.28% | +6.72% | +88.55% | +131.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.9M 7.35M 6.43M 5.5M 10.43M 700M 10.61M 71.04M 27.53M 343M 27.61M 27.01M 1.18B | 43.19M 53.82M 47.03M 40.27M 76.35M 5.12B 77.64M 520M 202M 2.51B 202M 198M 8.66B |
| Net income | -7.81M -9.73M -8.51M -7.28M -13.81M -927M -14.04M -94.05M -36.45M -455M -36.55M -35.76M -1.57B | 24.83M 30.94M 27.04M 23.15M 43.89M 2.95B 44.63M 299M 116M 1.44B 116M 114M 4.98B |
| Net Debt | -8.42M -10.49M -9.17M -7.85M -14.88M -999M -15.14M -101M -39.28M -490M -39.4M -38.54M -1.69B | -19.27M -24.01M -20.98M -17.97M -34.07M -2.29B -34.64M -232M -89.91M -1.12B -90.17M -88.21M -3.86B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-02 | CHF 0.2000 | -8.68% | 2,136,136 |
| 26-07-01 | CHF 0.2190 | +9.50% | 3,222,454 |
| 26-06-30 | CHF 0.2000 | -4.53% | 1,666,659 |
| 26-06-29 | CHF 0.2095 | -3.23% | 1,264,459 |
| 26-06-26 | CHF 0.2165 | -1.59% | 1,840,613 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RLF Stock
Select your edition
All financial news and data tailored to specific country editions
